DK1220950T3 - Genetiske toksicitetsmarkörer, deres fremstilling og anvendelse - Google Patents

Genetiske toksicitetsmarkörer, deres fremstilling og anvendelse

Info

Publication number
DK1220950T3
DK1220950T3 DK00962602T DK00962602T DK1220950T3 DK 1220950 T3 DK1220950 T3 DK 1220950T3 DK 00962602 T DK00962602 T DK 00962602T DK 00962602 T DK00962602 T DK 00962602T DK 1220950 T3 DK1220950 T3 DK 1220950T3
Authority
DK
Denmark
Prior art keywords
toxicity
methods
compounds
nucleic acid
preparation
Prior art date
Application number
DK00962602T
Other languages
Danish (da)
English (en)
Inventor
Bruno Tocque
Laurent Bracco
Fabien Schweighoffer
Original Assignee
Exonhit Therapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exonhit Therapeutics Sa filed Critical Exonhit Therapeutics Sa
Application granted granted Critical
Publication of DK1220950T3 publication Critical patent/DK1220950T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK00962602T 1999-09-13 2000-09-12 Genetiske toksicitetsmarkörer, deres fremstilling og anvendelse DK1220950T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911405A FR2798392B1 (fr) 1999-09-13 1999-09-13 Marqueurs genetiques de la toxicite, preparation et utilisations
PCT/FR2000/002503 WO2001020029A2 (fr) 1999-09-13 2000-09-12 Marquers genetiques de la toxicite, preparation et utilisations

Publications (1)

Publication Number Publication Date
DK1220950T3 true DK1220950T3 (da) 2004-08-02

Family

ID=9549766

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00962602T DK1220950T3 (da) 1999-09-13 2000-09-12 Genetiske toksicitetsmarkörer, deres fremstilling og anvendelse

Country Status (13)

Country Link
US (2) US6509153B1 (enExample)
EP (1) EP1220950B9 (enExample)
JP (1) JP2003509066A (enExample)
AT (1) ATE263255T1 (enExample)
AU (1) AU783310B2 (enExample)
CA (1) CA2380383A1 (enExample)
DE (1) DE60009530T2 (enExample)
DK (1) DK1220950T3 (enExample)
ES (1) ES2216958T3 (enExample)
FR (1) FR2798392B1 (enExample)
IL (1) IL148615A0 (enExample)
PT (1) PT1220950E (enExample)
WO (1) WO2001020029A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881571B1 (en) * 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
US7361488B2 (en) * 2000-02-07 2008-04-22 Illumina, Inc. Nucleic acid detection methods using universal priming
JP4836403B2 (ja) * 2001-08-24 2011-12-14 独立行政法人産業技術総合研究所 毒性物質の検出方法
GB0410105D0 (en) * 2004-05-06 2004-06-09 Amersham Biosciences Uk Ltd Method for characterising compounds
EP1856283A2 (en) * 2005-03-09 2007-11-21 DSMIP Assets B.V. Method for measuring and comparing the activity of biologically active compounds
WO2008073581A2 (en) * 2006-10-23 2008-06-19 The Uab Research Foundation Biomarkers for cancer sensitivity to an anti-cancer agent and uses thereof
DE102010024898B4 (de) * 2010-06-24 2012-10-25 Merck Patent Gmbh Genexpressionsanalysen zur Charakterisierung und Identifizierung genotoxischer Verbindungen

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4888278A (en) * 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US5985549A (en) * 1985-10-22 1999-11-16 University Of Massachusetts Non-isotopic in-situ hybridization method for detection of nucleic acids
US5057410A (en) * 1988-08-05 1991-10-15 Cetus Corporation Chimeric messenger RNA detection methods
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6309822B1 (en) * 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
US5521297A (en) * 1993-06-04 1996-05-28 Salk Institute Biotechnology/Industrial Associates Nucleic acids encoding human metabotropic glutamate receptors
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5529925A (en) * 1993-12-03 1996-06-25 St. Jude Children's Research Hospital Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma
US5484702A (en) * 1994-01-27 1996-01-16 Research Foundation Of The State University Of New York At Buffalo Method for preselecting recombinant clones containing a specific nucleic acid sequence and subsequent transformation with preselected clones
US5679541A (en) * 1994-02-14 1997-10-21 California Institute Of Technology Programmed cell death antagonist protein
PH31414A (en) * 1994-02-24 1998-10-29 Boehringer Ingelheim Int Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples.
US5767258A (en) * 1995-05-12 1998-06-16 The Johns Hopkins University School Of Medicine Cell cycle regulatory gene
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination
US5922535A (en) * 1995-11-07 1999-07-13 Huo; Li Identifying sequence differences in nucleic acid populations
US6881571B1 (en) * 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
FR2755984B1 (fr) * 1996-11-15 2002-12-27 Bourachot Philippe Borne escamotable
US6060240A (en) * 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
CA2225187A1 (en) * 1997-07-14 1999-01-14 Universite D'ottawa/ University Of Ottawa Xaf genes and polypeptides: methods and reagents for modulating apoptosis
US6849400B1 (en) * 1997-07-23 2005-02-01 Gen-Probe Incorporated Methods for detecting and measuring spliced nucleic acids
GB9717766D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Methods
EP1015624A2 (en) * 1997-09-17 2000-07-05 The Johns Hopkins University P53-induced apoptosis
EP1066402B1 (en) * 1998-02-23 2005-05-18 Phylonix Pharmaceuticals Inc. Methods of screening agents for activity using teleosts
JPH11262621A (ja) * 1998-03-17 1999-09-28 Ebara Corp 除湿空調装置
US6168920B1 (en) * 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins
WO2000012760A2 (en) * 1998-08-28 2000-03-09 Incyte Pharmaceuticals, Inc. Toxicological response markers
US6160105A (en) * 1998-10-13 2000-12-12 Incyte Pharmaceuticals, Inc. Monitoring toxicological responses
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
US7981844B2 (en) * 2001-06-21 2011-07-19 Verenium Corporation Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes

Also Published As

Publication number Publication date
ES2216958T3 (es) 2004-11-01
EP1220950A2 (fr) 2002-07-10
FR2798392B1 (fr) 2005-07-15
EP1220950B1 (fr) 2004-03-31
IL148615A0 (en) 2002-09-12
WO2001020029A2 (fr) 2001-03-22
DE60009530T2 (de) 2005-02-03
US20030059788A1 (en) 2003-03-27
ATE263255T1 (de) 2004-04-15
JP2003509066A (ja) 2003-03-11
FR2798392A1 (fr) 2001-03-16
US6509153B1 (en) 2003-01-21
PT1220950E (pt) 2004-07-30
DE60009530D1 (de) 2004-05-06
WO2001020029A3 (fr) 2001-11-29
EP1220950B9 (fr) 2004-11-03
CA2380383A1 (fr) 2001-03-22
AU783310B2 (en) 2005-10-13
AU7426900A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
Murphy et al. Association of high-molecular-weight proteins with microtubules and their role in microtubule assembly in vitro.
ATE480643T1 (de) Homogener nachweis von analyten
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
Lin et al. Fast kinetic study of yeast phenylalanyl-tRNA synthetase: role of tRNAPhe in the discrimination between tyrosine and phenylalanine
WO2020178162A8 (en) Exocyclic amine substituted coumarin compounds and their uses as fluorescent labels
BRPI0515012A (pt) substáncia quìmica, composição e formulação farmacêutica, método de tratamento, método de inibição de pelo menos uma enzima que utiliza atp e uso
WO2004048598A3 (en) Molecular nephrotoxicology modeling
DK1032705T3 (da) Probearrays og fremgangsmåder til at benytte probearrays til at skelne mellem DNA
BRPI0510716A (pt) uso de um agente de ligação bi-especìfico, agente de ligação bi-especìfico, composição de um agente de ligação bi-especìfico, e, kit
WO2006117596A8 (en) Nucleic acid probes and nucleic acid analog probes
DK0665886T3 (da) Omlejring af cyklinkomplekser og anvendelser, der er relateret dertil
DK1381697T3 (da) Cirkulær probe-amplifikation (CPA) af ringformede nukleinsyremolekyler
DK0980263T3 (da) Kombinationsprodukt, som kombinerer en nukleinsyre med en substans, der opløser den ekstracellulære matrix, til genterapi
WO2004063334A8 (en) Molecular cardiotoxicology modeling
DK1220950T3 (da) Genetiske toksicitetsmarkörer, deres fremstilling og anvendelse
DK1994149T3 (da) Nye fluorescerende proteiner og fremgangsmåder til anvendelse deraf
GB2430740A (en) System and method for tracking and quatitating chemical entites
WO2003064624A3 (en) Molecular hepatotoxicology modeling
Cann et al. Measuring kinase activity—a global challenge
Heidary et al. A light‐activated metal complex targets both DNA and RNA in a fluorescent in vitro transcription and translation assay
BR0303012A (pt) Avaliação de câncer colorretal
DE69943134D1 (de) Nukleinsäureamplifizierung und detektion von mykobacterium-spezies
DE69941690D1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
ATE325190T1 (de) Genetische screeningverfahren
Huang et al. Kinetic analysis of PI3K reactions with fluorescent PIP2 derivatives